Decreased temporal lobe phosphomonoesters in bipolar disorder - PubMed (original) (raw)
Decreased temporal lobe phosphomonoesters in bipolar disorder
R F Deicken et al. J Affect Disord. 1995.
Abstract
In vivo [31P]magnetic resonance spectroscopic imaging ([31P]MRSI) was performed on 12 unmedicated, euthymic bipolar patients and 14 control subjects to determine if there were alterations in high-energy P metabolism in the temporal lobes of bipolar patients. Compared with the control group, the patients with bipolar disorder demonstrated significantly lower phosphomonoesters (PME) in both the left and right temporal lobes. No other group differences in P metabolites or lateralized asymmetries were noted. This preliminary study provides support for altered temporal lobe phospholipid metabolism in bipolar disorder.
Similar articles
- 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia.
Calabrese G, Deicken RF, Fein G, Merrin EL, Schoenfeld F, Weiner MW. Calabrese G, et al. Biol Psychiatry. 1992 Jul 1;32(1):26-32. doi: 10.1016/0006-3223(92)90139-q. Biol Psychiatry. 1992. PMID: 1391294 - Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS.
Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y, Inubushi T, Takahashi S. Kato T, et al. Psychol Med. 1995 May;25(3):557-66. doi: 10.1017/s003329170003347x. Psychol Med. 1995. PMID: 7480436 - Abnormal frontal lobe phosphorous metabolism in bipolar disorder.
Deicken RF, Fein G, Weiner MW. Deicken RF, et al. Am J Psychiatry. 1995 Jun;152(6):915-8. doi: 10.1176/ajp.152.6.915. Am J Psychiatry. 1995. PMID: 7755123 - Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.
Fukuzako H. Fukuzako H. World J Biol Psychiatry. 2001 Apr;2(2):70-82. doi: 10.3109/15622970109027496. World J Biol Psychiatry. 2001. PMID: 12587188 Review. - Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.
Stork C, Renshaw PF. Stork C, et al. Mol Psychiatry. 2005 Oct;10(10):900-19. doi: 10.1038/sj.mp.4001711. Mol Psychiatry. 2005. PMID: 16027739 Review.
Cited by
- Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.
Yuksel C, Du F, Ravichandran C, Goldbach JR, Thida T, Lin P, Dora B, Gelda J, O'Connor L, Sehovic S, Gruber S, Ongur D, Cohen BM. Yuksel C, et al. Mol Psychiatry. 2015 Sep;20(9):1079-84. doi: 10.1038/mp.2015.13. Epub 2015 Mar 10. Mol Psychiatry. 2015. PMID: 25754079 - Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder.
MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C. MacDonald ML, et al. Bipolar Disord. 2006 Jun;8(3):255-64. doi: 10.1111/j.1399-5618.2006.00302.x. Bipolar Disord. 2006. PMID: 16696827 Free PMC article. - Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder.
Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, Inubushi T. Kato T, et al. J Psychiatry Neurosci. 1996 Jul;21(4):248-54. J Psychiatry Neurosci. 1996. PMID: 8754593 Free PMC article. Clinical Trial. - Biomarker screening for antenatal depression in women who underwent caesarean section: a matched observational study with plasma Lipidomics.
Wu Z, Zhao P, Long Z, Li J, Yang G, Zhang Q, Duan G, Li H. Wu Z, et al. BMC Psychiatry. 2019 Aug 27;19(1):259. doi: 10.1186/s12888-019-2241-1. BMC Psychiatry. 2019. PMID: 31455267 Free PMC article. Clinical Trial. - Mitochondrial dysfunction and psychiatric disorders.
Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Rezin GT, et al. Neurochem Res. 2009 Jun;34(6):1021-9. doi: 10.1007/s11064-008-9865-8. Epub 2008 Nov 1. Neurochem Res. 2009. PMID: 18979198 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials